Provided by Tiger Trade Technology Pte. Ltd.

Editas Medicine

2.65
-0.1201-4.34%
Volume:1.53M
Turnover:4.09M
Market Cap:405.43M
PE:-3.63
High:2.77
Open:2.77
Low:2.62
Close:2.77
52wk High:4.54
52wk Low:1.66
Shares:153.00M
Float Shares:115.00M
Volume Ratio:0.99
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7307
EPS(LYR):-1.8036
ROE:-118.82%
ROA:-23.29%
PB:3.85
PE(LYR):-1.47

Loading ...

Editas Medicine Q2 EPS $(0.15) Beats $(0.27) Estimate, Sales $11.900M Beat $2.800M Estimate

Benzinga Earnings
·
Aug 06

Editas Medicine Q2 Net Loss Narrows and Beats Estimates

Reuters
·
Aug 06

Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 Million

Reuters
·
Aug 06

Editas Medicine Announces Second Quarter 2026 Results and Business Updates

THOMSON REUTERS
·
Aug 06

Editas Medicine Q2 Basic EPS USD -0.15

THOMSON REUTERS
·
Aug 06

Editas Medicine Names Patrick Ellinor to Board, Elliott Levy to Step Down

Reuters
·
Aug 05

Editas Medicine Strengthens Board of Directors with Appointment of Patrick T. Ellinor, M.d., Ph.d.

THOMSON REUTERS
·
Aug 05

Genflow Appoints Gad Berdugo as Independent Non-executive Chairman

Reuters
·
Jul 13

Editas Medicine Shareholders Back Board, Pay and Auditor

TIPRANKS
·
Jun 19

Editas Medicine shareholders elect Connaughton, Levy as Class I directors at annual meeting

Reuters
·
Jun 19

Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference

GlobeNewswire
·
May 29

Editas Medicine preclinical data ‘looks highly supportive,’ says Evercore ISI

TIPRANKS
·
May 28

TD Cowen remains bullish on Editas Medicine after ‘compelling preclinical data’

TIPRANKS
·
May 28

BUZZ-Editas Medicine down after $125 mln stock-and-warrants offering

Reuters
·
May 26

Editas Medicine Announces Pricing of up to $319.4 Million Public Offering

THOMSON REUTERS
·
May 26

Editas Medicine Inc - Prices Public Offering of 55.56 Mln Shares and Warrants at $2.25 Each

THOMSON REUTERS
·
May 26

Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering

GlobeNewswire
·
May 26

Editas Medicine Suspends Existing At-The-Market Offering Prospectus

TIPRANKS
·
May 26

Editas Medicine Proposes Public Stock Offering; Shares Fall Pre-Bell

MT Newswires Live
·
May 26

Editas Showcases Promising EDIT-401 Data for Hyperlipidemia

TIPRANKS
·
May 26